WallStreetZenWallStreetZen

NASDAQ: EQRX
Eqrx Inc Stock

Open Broker Account
$3.78+0.27 (+7.69%)
Updated Dec 2, 2022
EQRX Price
$3.78
Fair Value Price
$5.61
Market Cap
$1.85B
52 Week Low
$2.63
52 Week High
$9.98
P/E
1.87x
P/B
1.32x
P/S
N/A
PEG
0.02x
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$145.69M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.1
Operating Cash Flow
-$262M
Beta
1.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

EQRX Overview

EQRx, Inc., a pharmaceutical company, develops treatments for oncology and immune-inflammatory diseases. Its pipeline programs include aumolertinib and sugemalimab, oncology assets that have shown assuring Phase 3 data, as well as multiple other clinical-stage programs. EQRx was incorporated in 2019 and is headquartered in Cambridge, MA.

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how EQRX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

EQRX ($3.78) is undervalued by 32.6% relative to our estimate of its Fair Value price of $5.61 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
EQRX ($3.78) is significantly undervalued by 32.6% relative to our estimate of its Fair Value price of $5.61 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
EQRX ($3.78) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more EQRX due diligence checks available for Premium users.

Be the first to know about important EQRX news, forecast changes, insider trades & much more!

EQRX News

Valuation

EQRX fair value

Fair Value of EQRX stock based on Discounted Cash Flow (DCF)
Price
$3.78
Fair Value
$5.61
Undervalued by
32.60%
EQRX ($3.78) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
EQRX ($3.78) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
EQRX ($3.78) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

EQRX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
1.87x
Industry
13.84x
Market
21.89x
EQRX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
EQRX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

EQRX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.32x
Industry
5.06x
EQRX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

EQRX price to earnings growth (PEG)

For valuing profitable companies with growth potential
EQRX is good value based... subscribe to Premium to read more.
PEG Value Valuation

EQRX's financial health

Profit margin

Revenue
$0.0
Net Income
-$85.1M
Profit Margin
0%
EQRX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$1.5B
Liabilities
$143.5M
Debt to equity
0.1
EQRX's short-term assets ($1.52B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EQRX's short-term assets ($1.52B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EQRX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$62.1M
Investing
$194.9M
Financing
$774.0k
EQRX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

EQRX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
EQRX$1.85B+7.69%1.87x1.32x
XNCR$1.85B+2.49%57.15x2.56x
RVNC$1.82B+1.79%-5.65x12.51x
CPRX$1.80B+3.85%26.57x6.66x
IMVT$1.90B+5.84%-9.59x4.79x

Eqrx Stock FAQ

What is Eqrx's quote symbol?

NASDAQ: EQRX) Eqrx trades on the NASDAQ under the ticker symbol EQRX. Eqrx stock quotes can also be displayed as NASDAQ: EQRX.

If you're new to stock investing, here's how to buy Eqrx stock.

What is the 52 week high and low for Eqrx (NASDAQ: EQRX)?

(NASDAQ: EQRX) Eqrx's 52-week high was $9.98, and its 52-week low was $2.63. It is currently -62.12% from its 52-week high and 43.73% from its 52-week low.

How much is Eqrx stock worth today?

(NASDAQ: EQRX) Eqrx currently has 488,433,373 outstanding shares. With Eqrx stock trading at $3.78 per share, the total value of Eqrx stock (market capitalization) is $1.85B.

Eqrx stock was originally listed at a price of $11.19 in Apr 7, 2021. If you had invested in Eqrx stock at $11.19, your return over the last 1 years would have been -66.22%, for an annualized return of -66.22% (not including any dividends or dividend reinvestments).

How much is Eqrx's stock price per share?

(NASDAQ: EQRX) Eqrx stock price per share is $3.78 today (as of Dec 2, 2022).

What is Eqrx's Market Cap?

(NASDAQ: EQRX) Eqrx's market cap is $1.85B, as of Dec 5, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Eqrx's market cap is calculated by multiplying EQRX's current stock price of $3.78 by EQRX's total outstanding shares of 488,433,373.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.